Concepedia
Statistics
Publications
30
Citations
3.5K
H-Index
28
Active since
1987
Affiliations
Roche (Switzerland)(Current)
MSD (UK) Limited (United Kingdom)
Merck & Co., Inc., Rahway, NJ, USA (United States)
Royal Veterinary College
University of Toronto
R. Gill is an author at Roche (Switzerland) specializing in neuroscience, neuropharmacology, and life sciences.
Publications per year
1987–2004
Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil
R. Gill, AC Foster, GN Woodruff · Journal of Neuroscience · 1987 · 643 citations · Full text
Medicine, Neuroscience, Pharmacology +17
The Effect of MK-801 on Cortical Spreading Depression in the Penumbral Zone following Focal Ischaemia in the Rat
R. Gill, Peter Andiné, Lars Hillered et al. · Journal of Cerebral Blood Flow & Metabolism · 1992 · 289 citations
Life Sciences, Neurobiology, Neuroscience +15
MK-801 is neuroprotective in gerbils when administered during the post-ischaemic period
R. Gill, Alan C. Foster, G.N. Woodruff · Neuroscience · 1988 · 277 citations
Medicine, Neurobiology, Neuroscience +5
Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene.
Paul A. Hamel, R. Gill, Robert A. Phillips et al. · Molecular and Cellular Biology · 1992 · 235 citations
Life Sciences, Cell Biology, Genetics +17
Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation
AC Foster, R. Gill, GN Woodruff · Journal of Neuroscience · 1988 · 215 citations · Full text
Life Sciences, Neurobiology, Neuroscience +17
1–5 of 30